Your browser doesn't support javascript.
loading
Hepatotoxicity of copper sulfide nanoparticles towards hepatocyte spheroids using a novel multi-concave agarose chip method.
Jiang, Tianyan; Guo, Haoxiang; Xia, Ya-Nan; Liu, Yun; Chen, Dandan; Pang, Guibin; Feng, Yahui; Yu, Huan; Wu, Yanxian; Zhang, Shaodian; Wang, Yangyun; Wang, Yong; Wen, Hairuo; Zhang, Leshuai W.
Afiliação
  • Jiang T; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Guo H; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Xia YN; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Liu Y; Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.
  • Chen D; Shanghai R&D Centre for Standardization of Chinese Medicines, Shanghai, 201210, PR China.
  • Pang G; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Feng Y; State Key Laboratory of Bioreactor Engineering, East China University of Science & Technology, Shanghai, PR China.
  • Yu H; Department of Science & Technology, The Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, 610051, PR China.
  • Wu Y; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Zhang S; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Wang Y; The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, 215004, PR China.
  • Wang Y; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Wen H; School of Radiation Medicine & Protection, State Key Laboratory of Radiation Medicine & Protection, School for Radiological & Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 21
  • Zhang LW; Beijing Key Laboratory, National Center for Safety Evaluation of Drugs, National Institutes for Food & Drug Control, Beijing, 100176, PR China.
Nanomedicine (Lond) ; 16(17): 1487-1504, 2021 07.
Article em En | MEDLINE | ID: mdl-34184559
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Doença Hepática Induzida por Substâncias e Drogas Limite: Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Doença Hepática Induzida por Substâncias e Drogas Limite: Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2021 Tipo de documento: Article